The importance of NO
a b s t r a c t
The importance of NO
• to immunity is highlighted by the diversity of pathogens that require NO
• -defensive systems to establish infections. Proteases have been identified to aid pathogens in surviving macrophage attack, inspiring us to investigate their role during NO
• stress in Escherichia coli. We discovered that the elimination of ClpP largely impaired NO • detoxification by E. coli. Using a quantitative model of NO • stress, we employed an ensemble-guided approach to identify the underlying mechanism.
Iterations of in silico analyses and corresponding experiments identified the defect to result from deficient transcript levels of hmp, which encodes NO • dioxygenase. Interestingly, the defect was not confined to hmp, as ΔclpP imparted widespread perturbations to the expression of NO
• -responsive
genes. This work identified a target for anti-infective therapies based on disabling NO
• defenses, and demonstrated the utility of model-based approaches for exploring the complex, systems-level stress exerted by NO • .
& 2015 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.
Introduction

NO
• is an important signaling molecule in humans, modulating physiological functions ranging from vasodilation and neurotransmission to innate immunity (Toledo and Augusto, 2012; Nathan, 1992; Bowman et al., 2011) . As part of the immune response, NO • is synthesized by phagocytic cells, such as macrophages, to disable pathogens (Bowman et al., 2011; Fang, 2004) through inhibition of processes such as respiration (Yu et al., 1997) , amino acid biosynthesis (Hyduke et al., 2007) , and the tricarboxylic acid (TCA) cycle (Richardson et al., 2011) . The importance of NO • in the immune response is emphasized by the growing list of pathogens, including Pseudomonas aeruginosa (Kakishima et al., 2007) , Vibrio cholerae (Stern et al., 2012) , Mycobacterium tuberculosis (Darwin et al., 2003) , Salmonella enterica serovar Typhimurium (Stevanin et al., 2002) , and pathogenic strains of Escherichia coli (Svensson et al., 2010; Shimizu et al., 2012) , for which NO • detoxification or repair systems have been identified as virulence factors (Robinson et al., 2014b) . In uropathogenic E. coli (UPEC), for example, a mutant lacking NO
• dioxygenase (Δhmp) was outcompeted by wild-type (WT) in a mouse infection model (Svensson et al., 2010) . More recently, the presence of a functional NO • reductase (NorV) in enterohemorrhagic E. coli (EHEC) strains has been found to correlate with higher incidences of hemolytic uremic syndrome (HUS), a lifethreatening condition (Kulasekara et al., 2009 ). Further study found that EHEC possessing functional norV exhibited increased survival within macrophages compared to strains harboring the inactive norVs gene (Shimizu et al., 2012) . Furthermore, murine infection studies have shown that deletion or inhibition of inducible nitric oxide synthase (iNOS), the enzyme responsible for NO • production in phagocytes (MacMicking et al., 1997) , increases the bacterial load and mortality rate of infected hosts for a wide variety of pathogens (Richardson et al., 2011; MacMicking et al., 1995; Chan et al., 1995; Bang et al., 2006) . These data suggest that sabotaging bacterial NO
• defenses could constitute an effective anti-infective strategy for many pathogens. However, known inhibitors for the obvious network targets, such as NO • dioxygenase (Hmp), are not therapeutically applicable, as they face issues such as toxicity toward humans (e.g., cyanide (Stevanin et al., 2000) ) or poor transport into Gramnegative bacteria (e.g., imidazole (Helmick et al., 2005) ). Therefore, additional targets that could be leveraged to disable bacterial NO
• defenses are necessary to realize therapies based on potentiation of NO • toxicity in pathogens.
Bacterial proteases have recently been identified as virulence factors for numerous pathogens (Gur et al., 2013) , and more specifically, been found to enhance survival within macrophages (Takaya et al., 2003; Park et al., 2010) . For example, the Hip1 protease in M. tuberculosis was identified to aid in the evasion of immune attack by suppressing the proinflammatory response and the activation of macrophages (Madan-Lala et al., 2011; NaffinOlivos et al., 2014) . The ClpP protease has been found to be essential for the survival of both Listeria monocytogenes (Gaillot et al., 2000) and Streptococcus pneumonia (Park et al., 2010) in macrophages, whereas the Lon protease was found to be important for survival of S. Typhimurium in macrophages (Takaya et al., 2003) . These studies, in conjunction with the knowledge that NO
• is a major component of the macrophage antimicrobial arsenal, suggested that proteases may be important mediators of bacterial NO • defense systems.
However, it was unknown whether proteases participate in the NO • stress response of E. coli. Considering the importance of NO • tolerance to EHEC and UPEC virulence (Svensson et al., 2010; Shimizu et al., 2012) , we investigated whether proteases were involved in the NO • defense network of E. coli.
Here, we evaluated the NO • sensitivity of E. coli deficient in each of the three major ATP-dependent proteases (Clp, Lon, and Hsl), and discovered that ΔclpP exhibited a substantial increase in NO
• -mediated stasis, and decrease in NO
• clearance rate, compared to WT. We found the phenotype to also be present in EHEC, and mechanistically explored the result using a quantitative modeling approach to guide experimentation. Specifically, a kinetic model of the E. coli NO • biochemical network was used to generate an ensemble of mechanistic hypotheses that could explain the ΔclpP phenotype, and was subjected to experimentally-tractable perturbations in silico to identify conditions that would allow for discrimination between mechanisms. The in silico perturbations were executed experimentally and the results were used to eliminate mechanisms that were inconsistent with the data. This process was iterated until we determined that a deficiency in hmp transcript levels was responsible for the increased NO
• sensitivity of ΔclpP. Using RNA sequencing (RNA-Seq), we found that the deletion of ClpP had a widespread impact on transcript levels under NO • stress. These results demonstrate the utility of ensemble-guided approaches for the mechanistic dissection of phenotypes associated with the broadly reactive immune antimicrobial NO
•
, and suggest that ClpP may be an attractive target for therapies to treat pathogenic E. coli, such as EHEC.
Results
NO
• sensitivity of E. coli protease mutants
To determine if protease activity contributes to E. coli NO
• defense, single gene knockout mutants of each of the three major ATP-dependent proteases (ΔclpP, Δlon, and ΔhslV) were evaluated for NO • sensitivity relative to the WT (Fig. 1A) . A fourth protease, FtsH, was excluded from the investigation because it is required for growth (Jayasekera et al., 2000) . Cultures were grown to exponential phase, and treated with 2 mM DPTA NONOate, which dissociates to release 2 NO • molecules per parent compound. • detoxification activity similar to that of WT, whereas ΔclpP NO • clearance was over two-fold slower (Fig. 1B) . This phenotype was complemented with a plasmid-borne copy of clpP expressed from its native promoter (pJR01), unequivocally demonstrating that the phenotype was associated with loss of ClpP (Fig. S1 ).
To assess whether the phenotype is present in pathogenic E. coli, we performed a similar analysis of NO
• sensitivity for EHEC and its ΔclpP mutant. NO
• has been suggested to play a critical role in EHEC pathogenesis, where mutants lacking the detoxification enzyme NO • reductase (NorV) were found to exhibit reduced survival in macrophages (Shimizu et al., 2012) , and infection outbreaks involving strains possessing a functional NorV (as opposed to the inactive NorVs) correlated with a higher incidence of hemolytic uremic syndrome (HUS) (Kulasekara et al., 2009 give rise to a broad, complex biochemical reaction network that can be difficult to interrogate without the use of mathematical models (Bowman et al., 2011; Robinson et al., 2014b; Robinson and Brynildsen, 2013 (Bowman et al., 2011; Robinson et al., 2014b; Robinson and Brynildsen, 2013) . Our previous work has demonstrated the utility of computational modeling for quantitatively studying the NO
• biochemical network of E. coli and its response to various genetic and environmental perturbations (Robinson and Brynildsen, 2013; Robinson et al., 2014a Fig. 2A) . Since ClpP is a novel component of the NO • response network, and thus absent from the knowledgebase upon which the model was constructed (Robinson and Brynildsen, 2013) , the model incorrectly predicted WT [NO
•
] dynamics for ΔclpP. To identify the mechanism by which ΔclpP impairs NO
• detoxification, parameter constraints were released one by one, and allowed to vary (increase or decrease) within two-fold of their original value to determine those with the greatest capacity to reconcile simulations with experimental data from ΔclpP cultures.
The analysis identified seven parameters whose adjustment could largely reduce the error (quantified as the sum of the squared residuals; SSR) between the model and ΔclpP experimental data (Fig. 2B) , as well as many parameters that could not. This information was useful because it allowed effort to be focused on elements likely to give rise to the ΔclpP phenotype, rather than those that were likely to be negligible contributors. For example, it allowed us to disregard initial Hmp concentration and rate of enzyme degradation as potential explanations for the phenotype.
The seven parameters that could largely reconcile the model predictions with ΔclpP data were all associated with Hmp, which was anticipated given the importance of the enzyme to E. coli NO ] curve. The parameters were allowed to vary within one order of magnitude of the WT value, yielding 127 distinct models that were each capable of accurately predicting the experimental data (Fig. 2C ). This ensemble represented 127 potential mechanisms by which the ΔclpP mutation could perturb the E. coli NO • response network. To identify the correct mechanism, we performed in silico experiments with the ensemble to determine genetic and environmental perturbations that would allow discrimination between the ensemble members. The corresponding experiments were then performed, allowing reduction of the ensemble by removal of models that were inconsistent with the new data. This model discrimination process was iterated until convergence upon a single mechanism was achieved.
Effect of ΔclpP on Hmp catalytic activity
Three of the parameters found to reconcile model simulations with ΔclpP data govern the catalytic activity of Hmp. Ensemble members with modifications to these parameters predicted that Hmp in ΔclpP was affected in such a way as to reduce its NO • detoxification rate, yielding the observed slower NO
• clearance than WT. To evaluate whether a reduction in Hmp catalytic activity was responsible for the impaired NO
• detoxification in ΔclpP, we rationalized that the enzyme could be pre-expressed prior to NO
• stress to achieve equal initial Hmp concentrations, and a translation inhibitor could be used to halt any additional protein (Fig. S2) . Ensemble members involving a perturbation to Hmp catalytic parameters (112 models) were thus rejected, reducing the ensemble size to 15 models, all of which predicted that similar Hmp abundance will result in similar NO • clearance.
Effect of ΔclpP on gene expression from the hmp promoter
The remaining ensemble members were models with differences in parameters governing Hmp translation and/or transcript abundance. To discriminate between these mechanisms, we simulated mRNA and protein levels from the hmp promoter (P hmp ) driving gfp expression. hmp was removed from these simulations in order to maintain identical NO
• environments between WT and ΔclpP, and was replaced by gfp to facilitate real-time quantification of protein levels in subsequent experiments. Delivery of (Fig. S3A-C) . However, upon conducting the corresponding experimental measurements, the clpP À culture was unable to achieve hmp-gfp transcript levels comparable to those of clpP þ , despite full induction (1 mM IPTG) from an orthogonal promoter (Text S1, Fig. S3D-F (Fig. 5A-C) , whereas those with perturbations to both transcription and translation predicted mRNA levels different from that of clpP þ (Fig. 5D-F) .
The associated experiments were performed using an IPTGinducible hmp-gfp expression system (pJR05 ] curve, GFP fluorescence, and transcript levels were quantified (Fig. 5G-I ). In accordance with the in silico analysis, clpP À was fully induced (1 mM IPTG), while the induction of clpP þ was reduced until a rate of Hmp-GFP production similar to that of clpP À was achieved (10 μM IPTG). Consistent with previous results (Fig. 3) , similar protein levels resulted in similar NO
• clearance between the two strains, leaving model discrimination to rely on whether a difference in mRNA levels was observed. The associated mRNA concentrations were quantified, and did not differ significantly between the two strains (p 40.05 for all points; two-tailed t-test with unequal variance), supporting mechanisms that described the ΔclpP phenotype as only involving a perturbation to transcript levels. Mechanisms yielding different transcript levels for similar protein concentrations were therefore eliminated from the ensemble, reducing the size from 14 to 4 models (Fig. S4 ).
Evaluation of contributions from transcript degradation
The remaining ensemble included mechanisms attributing the NO • -sensitivity of ΔclpP to attenuated mRNA production, increased mRNA degradation, or some combination of the two. To differentiate between these mechanisms, an in silico experiment was conducted wherein the cells were initialized with a nonzero gfp mRNA concentration (100 nM), but transcription was inactivated during NO
• stress, (Fig. 6A) .
Experimentally, the simulated conditions were reproduced using
Δhmp and ΔhmpΔclpP cells transformed with a plasmid harboring IPTG-inducible gfp (pJR06). Exponential-phase cultures were induced with 1 mM IPTG for 15 min, washed and delivered to a bioreactor containing fresh media with 500 μg/ml rifampicin (RIF) to halt transcription, and immediately dosed with 250 μM DPTA NONOate.
To confirm that transcription was arrested upon treatment, the assay was repeated identically, except the IPTG was added immediately after RIF treatment, rather than 15 min prior (Fig. S5) . The concentration of GFP was quantified with fluorescence readings, and 500 μL of culture was removed at time zero (immediately prior to treatment) to confirm similar starting concentrations of gfp mRNA using qPCR. The resulting [GFP] profile was similar in shape to that predicted by the model, with an increasing concentration that plateaued as mRNA was depleted, and the data revealed a similar rate of mRNA degradation in clpP þ and clpP À (Fig. 6B ). This reduced the ensemble to a single mechanism that attributed the NO
• -sensitive phenotype of ΔclpP to be the result of attenuated hmp transcription.
Assessing the breadth of the ΔclpP transcription defect 2.3.1. Investigation of an orthogonal expression system
The ensemble modeling approach narrowed the source of the impaired NO
• detoxification activity of ΔclpP to an inability to achieve WT levels of hmp mRNA transcripts. Interestingly, the presence of this effect during the ensemble dissection experiments utilizing an independent, orthogonal promoter (P T5 ) suggested that the impact of
ΔclpP on transcript levels under NO
• stress may be widespread. To further investigate the breadth of the ΔclpP phenotype, a completely independent expression system was used, where the IPTG-inducible P T5 promoter was replaced with an anhydrotetracycline (aTc)-inducible P LtetO-1 , and GFP replaced with mCherry (pJR07). This alternate plasmid was transformed into Δhmp and ΔhmpΔclpP backgrounds (each possessing a P N25 -tetR chromosomal knock-in) for comparison of mCherry transcript and protein production under identical NO
• environments. Expression of mCherry was induced with the addition of 50 ng/ml aTc, and protein concentration was monitored fluorometrically. In the absence of NO • stress, the clpP þ and clpP À cultures produced similar concentrations of mCherry (Fig. S6A) . However, upon treatment with 250 μM DPTA NONOate, the clpP À cells exhibited significantly lower concentrations of mCherry than clpP þ , an effect that was again reflected in the associated mRNA concentrations ( Fig. S6B and S6C ). The observation of this transcription defect for an entirely different promoter, inducer, mRNA, and protein was supportive of a widespread effect of ΔclpP on transcript levels. To explore this effect further, a transcriptomic investigation was conducted using RNA-Seq. and was just beginning to diverge (Fig. 1B) . RNA was extracted and purified from WT and ΔclpP cells, and further processed to yield mRNA (see Section 4). The mRNA was analyzed using RNA-Seq, and the results were evaluated for differences in transcript levels between untreated and NO
RNA-Seq analysis of NO
• -treated samples, and between WT and
ΔclpP.
In agreement with previous transcriptomic analyses of NO
• -stressed E. coli under aerobic conditions (Hyduke et al., 2007; Pullan et al., 2007) , genes exhibiting a large expression increase for WT in response to NO
• included those related to detoxification (norVW, hmp, and hcp), repair (ytfE), and respiration (cydAB). Analogously, in agreement with previous comparisons of ΔclpP and WT under unstressed conditions, genes involved in the production of curli (csg genes) and fimbriae (fim genes) were largely reduced in ΔclpP due to repression by the flagellar system (Pesavento et al., 2008 (Table S1 ). Given the observed perturbation to hmp mRNA levels, we considered the possibility that the ΔclpP mutation was affecting one or more of the transcription factors associated with the hmp promoter (NsrR, FNR, Fur, or MetR) (Keseler et al., 2013) . We found that the mRNA counts of the regulators themselves were not significantly different between WT and ΔclpP, either in the presence or absence of NO
• . We next inspected the regulons of the transcription factors by considering genes without significant differences between WT and ΔclpP levels prior to treatment that exhibited significant, Z10-fold changes in transcript levels in WT upon treatment with NO (Table S2 ). This suggested that the effect of ΔclpP cannot be pinpointed to a single transcription factor acting on the hmp promoter, but instead affects transcription more broadly.
Identification of interaction partners of ClpP that contribute to its effect on the NO
• response network
Upon confirming that ClpP was exerting a global effect on transcript levels under NO
• stress, we sought to determine how ClpP, a protease, exerts this control. ClpP is a serine protease which targets a large number of substrates in the cell, ranging from SsrAtagged proteins to sigma factors, with help from its ATPase adapter (unfoldase) subunits ClpA and ClpX (Gur et al., 2013) . Therefore, deletion mutants lacking either ClpA, ClpX, or both ClpA and ClpX, were evaluated for their ability to resume growth following NO
• stress and to detoxify NO • (Fig. 7) .
Relative to WT, the ΔclpA and ΔclpX mutants exhibited a 1-2 h longer delay in growth resumption after NO • stress and a slower rate of NO • detoxification ( $ 40% increase in clearance time), but the effect was attenuated relative to that of ΔclpP. However, the double mutant lacking both ClpP adapters (ΔclpAΔclpX) Fig. S8 ).
Collectively, these data demonstrate that the role of ClpP in regulating transcript levels under NO
• stress requires ClpA and ClpX activity. Although the substrates degraded by ClpP to promote NO
• detoxification are beyond the known ClpP degradation targets that broadly impact cellular physiology and/or transcription, or are a combination of multiple regulatory systems, the data presented here convincingly demonstrate that inhibiting ClpP protease would be an effective means to potentiate NO • toxicity in E. coli.
Discussion
Antibiotic-resistant infections continue to increase in frequency and severity while the supply of new antibiotics continues to diminish (Centers for Disease Control and Prevention (CDC), 2013; Bush et al., 2011; Talbot et al., 2006) . To address this growing therapeutic gap, alternative anti-infective approaches, such as antivirulence therapies, are being explored (Fernebro, 2011; Cegelski et al., 2008) . Unlike traditional antibiotics, which target essential cellular processes, antivirulence therapies are designed to disrupt critical host-pathogen interactions. This focuses selective pressure to the host environment during the infection process -the time and place it is needed -which minimizes the driving force for resistance development (Rasko and Sperandio, 2010) . Furthermore, antivirulence treatments are less likely to deleteriously affect commensal bacteria, which is an unfavorable side effect of many traditional antibiotics that can lead to complications including secondary infections by opportunistic pathogens, such as Clostridium difficile (Dethlefsen and Relman, 2011) . Given the strong influence of the bacterial NO
• defense network on virulence for a broad range of pathogens, this network is a prime target for antivirulence therapies. Unfortunately, the major NO • detoxification systems, such as NO
• dioxygenase and NO • reductase, have proven to be difficult to drug due to the host toxicity and poor transport into bacterial cells of known inhibitors (e.g., cyanide (Stevanin et al., 2000) and imidazole (Helmick et al., 2005) ). Therefore, the identification of additional targets that can be leveraged to disable bacterial NO • defense systems will facilitate the development of antivirulence treatments. Here, we identified ClpP and its ATPase adapters ClpA and ClpX as a critical mediators of the E. coli NO
• stress response. Deletion of ClpP or both ClpA and ClpX crippled the ability of E. coli to detoxify NO
• from the environment, thereby prolonging bacteriostasis and enhancing the damaging effects of NO
• . Furthermore, the impaired NO
• detoxification caused by the loss of ClpP was shown to translate to pathogenic E. coli (O157:H7). This data suggests that ClpP protease activity may be an effective target for antivirulence therapies against pathogenic E. coli if effective inhibitors can be found. Interestingly, the importance of ClpP to the pathogenesis of a number of species including L. monocytogenes (Gaillot et al., 2000) , S. pneumoniae (Park et al., 2010) , Staphylococcus aureus (Michel et al., 2006) , and EHEC (Iyoda and Watanabe, 2005) has already prompted the search for inhibitor compounds (Compton et al., 2013; McGillivray et al., 2012) . Bacterial protease activity has previously been found to contribute to the NO
• defenses of other pathogens (Darwin et al., 2003; Park et al., 2010) . For example, M. tuberculosis mutants lacking core subunits of the proteasome displayed enhanced sensitivity to acidified nitrite (Darwin et al., 2003) , and an iNOS inhibitor improved the viability of a S. pneumoniae ΔclpP mutant that exhibited decreased survival within untreated macrophages (Park et al., 2010) . However, the mechanism bridging protease activity to NO • defense in both of these studies was not explored, though it was speculated that the protease could be responsible for digesting NO
• -damaged proteins that may otherwise accumulate to toxic levels within the cell (Darwin et al., 2003) . In this work, not only did we identify a novel NO • -defensive role for ClpP in E. coli, but we investigated the underlying mechanism and found ClpP to be a global regulator of transcript levels under NO
• stress in E. coli, an effect of which was to promote NO • detoxification through increased levels of hmp mRNA. This discovery was facilitated by an ensemble-guided approach, where a collection of 127 models was generated to capture the [NO • ] dynamics of ΔclpP, and a model discrimination procedure was iterated until a single model remained, which attributed the increased NO • sensitivity of
ΔclpP to reduced transcription of hmp under NO
• stress. This approach is especially useful for analyzing phenotypes involving broadly reactive molecules such as NO • , for which the biochemistry is dictated by complex networks of reactions and interactions. Ensemble modeling is a methodology that has previously been employed to computationally explore systems for which uncertainty exists in parameter values and/or network structure Hatzimanikatis, 2006a, 2006b; Kuepfer et al., 2007; Tran et al., 2008; Rizk and Liao, 2009; Mišković and Hatzimanikatis, 2011; Jia et al., 2012; Brynildsen et al., 2013; Zomorrodi et al., 2013; Khodayari et al., 2014; Lee et al., 2014; Adolfsen and Brynildsen, 2015) . For example, Wang and Hatzimanikatis (2006b) used a Monte Carlo method to address kinetic parameter uncertainty in a metabolic control analysis (MCA) study of Saccharomyces cerevisiae central carbon metabolism, and identified major differences in control schemes between batch and chemostat culturing conditions. Measured concentrations of metabolites involved in the S. cerevisiae trehalose pathway were used by Jia et al. (2012) to generate an ensemble of models, from which randomly-selected models were shown to capture the data equally well. Tran et al. (2008) demonstrated how an ensemble of E. coli central metabolism models with known steady-state parameters, but unknown kinetics, could be filtered using a model discrimination process, and ultimately used to predict perturbation phenotypes. The target-of-rapamycin (TOR) pathway of S. cerevisiae was studied by Kuepfer et al. (2007) using an ensemble of 19 different possible network structures, where guided experiments were used to reduce the ensemble, revealing the importance of the Tap42p-Tip41p complex formation in signal control.
The study described here demonstrates yet another application of an ensemble-guided approach, complementing the growing body of the literature on the use of ensemble modeling to analyze biochemical networks. We anticipate that ClpP may constitute an effective antivirulence target, helping to mitigate the mounting crisis of antibiotic resistance, and that the ensemble-guided approach will prove useful for studying NO
• stress in different conditions and pathogens, as well as other broadly reactive immune antimicrobials such as H 2 O 2 .
Materials and methods
Bacterial strains and plasmids
The bacteria used in this study were E. coli K-12 MG1655 and enterohemorrhagic E. coli O157:H7 TUV93-0. All mutants and transformants were derived from one of these two parent strains, and are described in Table S3 .
Bioreactor
To allow continuous [NO
• ] measurements in a growing culture, all assays (unless stated otherwise) were conducted in a stirred batch bioreactor, identical to our previous studies (Robinson and Brynildsen, 2013; Robinson et al., 2014a) . The bioreactor consisted of a disposable 50 ml conical tube (Falcon) suspended in a 37 1C stirred water bath, and it contained 10 ml of growth media. The culture was continuously stirred with a 0.5 in. magnetic stir bar, and was open to ambient air. 
, which dissociates to release 2 molecules of NO • per parent compound.
Absorbance and fluorescence measurements
Cell concentration (optical density at 600 nm; OD 600 ) and fluorescence (485/515 nm excitation/emission for GFP, or 580/ 610 nm excitation/emission for mCherry) were quantified using a Synergy TM H1 Hybrid Microplate Reader.
NO
• -stressed growth assay E. coli were grown aerobically from a À 80 1C frozen stock in 1 ml LB at 37 1C and 250 rpm for 4 h. 10 mL of the LB pre-culture was used to inoculate 1 ml of MOPS minimal media (Teknova) with 10 mM glucose, which was grown overnight (16 h) at 37 1C and 250 rpm. The overnight culture was inoculated into 2 ml of fresh MOPSþglucose to an OD 600 of 0.01, and grown until midexponential phase (OD 600 ¼0.2). The exponential-phase culture was quickly transferred to two separate test tubes and diluted with fresh, pre-warmed (37 1C) MOPS þglucose to achieve identical 1 ml cultures at an OD 600 of 0.1. One culture was dosed immediately with 2 mM DPTA NONOate, while the other was treated only with the DPTA NONOate solvent (0.14 mM final [NaOH] ). Both cultures were grown at 37 1C and 250 rpm for 10 h, with OD 600 measured hourly.
• consumption assay E. coli from a À 80 1C frozen stock were grown aerobically in LB for 4 h, and MOPS minimal media with 10 mM glucose for 16 h (37 1C and 250 rpm). The overnight culture was inoculated into 20 ml of fresh MOPSþglucose media in a 250 ml baffled shake flask to an initial OD 600 of 0.01, and grown at 37 1C and 250 rpm until OD 600 ¼ 0.2. The culture was centrifuged for 3 min at 15,000 rpm, resuspended in fresh pre-warmed (37 1C) MOPSþglucose, centrifuged for an additional 3 min at 15,000 rpm, and again resuspended in prewarmed MOPSþ glucose. The resuspension was delivered to the bioreactor to a final OD 600 of 0.05, and dosed immediately with 250 mM DPTA NONOate.
Hmp-GFP pre-expression NO
• consumption assay
Translationally-fused Hmp-GFP was placed under the control of an IPTG-inducible P T5 promoter on a plasmid (pJR03), and transformed into Δhmp and ΔhmpΔclpP strains. The strains were grown identically as described for the NO
• consumption assay (Section 4.6), except 15 min prior to the flask cultures reaching a 0.2 OD 600 , 50 μM IPTG was delivered to induce expression of Hmp-GFP. After 15 min of induction, the cells were centrifuged and washed in fresh, pre-warmed MOPSþglucose media containing 50 μg/ml CAM to prevent further protein synthesis. Meanwhile, the bioreactor was loaded with 10 ml of fresh MOPSþ glucose media (with 50 μg/ml CAM), and dosed with 250 μM DPTA NONOate, allowing the NO
• to achieve a relatively stable concentration ($10 min after dose) by the time the washing steps were complete. A portion of the CAMtreated cells were delivered to the NO
• -treated media to a final OD 600 of 0.05, while another portion was diluted into a microplate (OD 600 ¼ 0.2 to enhance signal intensity) to quantify GFP fluorescence. As controls, the assay was performed identically without induction (IPTG excluded), or using the empty plasmid (hmp-gfp coding sequence excluded) (Fig. S2 ).
Hmp-GFP induction-tuning assay
The IPTG-inducible, fused Hmp-GFP expression system described for the Hmp-GFP pre-expression NO
• consumption assay (Section 4.7) was transferred to a lower-copy plasmid backbone (pUA66 (Zaslaver et al., 2006) ) to facilitate tighter, more finely tuned expression of the protein (yielding pJR05). 
mRNA degradation rate assay
A GFP expression plasmid was constructed by cloning gfp into the pQE-80L vector (yielding pJR06), allowing IPTG-inducible expression from the P T5 promoter, and this was transformed into Δhmp and ΔhmpΔclpP strains. The strains were grown identically as described for the NO
• consumption assay (Section 4.6), but induced with 1 mM IPTG for 15 min prior to centrifugation and washing. Cells were resuspended in fresh, pre-warmed (37 1C) MOPS minimal media with 10 mM glucose, and delivered to the bioreactor (to a final OD 600 of 0.05) containing 10 ml of fresh MOPS glucose media with 500 μg/ml rifampicin (RIF) to halt transcription. The bioreactor culture was then immediately dosed with 250 μM DPTA NONOate, and GFP fluorescence was monitored every 5 min for the first 15 min, followed by every 15 min for the next 45 min. Fluorescence values of identically-treated, but uninduced (no IPTG) cells were also obtained to be subtracted as background. In addition, a 500 μL sample of culture was removed immediately prior to treatment at time zero for gfp mRNA quantification using qPCR. Finally, to confirm that transcription was halted by RIF, the experiment was repeated identically except 1 mM IPTG was added at the time of RIF treatment and DPTA NONOate dose, rather than 15 min prior, and fluorescence was monitored. A negligible increase in fluorescence over the course of the assay confirmed that transcription was sufficiently inhibited (Fig. S5) .
P hmp -gfp reporter assay
An hmp transcriptional reporter was constructed by placing gfp under control of the hmp promoter (P hmp , 250 bp of the 5 0 UTR directly upstream of the hmp start codon) on the pUA66 plasmid (Zaslaver et al., 2006 ) (yielding pJR04), and transformed into Δhmp and ΔhmpΔclpP strains. The cells were grown and treated with 250 μM DPTA NONOate, identically as described for the NO • consumption assay (Section 4.6). GFP fluorescence was measured every 0.5 h. At 0 h (before dose), 0.5 h, 1 h, and 2 h, 500 μL of culture was removed for subsequent RNA purification and qPCR analysis.
4.11. Real-time quantitative PCR (qPCR) 4.11.1. RNA purification To harvest RNA, 500 μL of culture was removed and immediately mixed with 1 ml of RNAprotect Bacteria Reagent (Qiagen) to stabilize the RNA. Purification was performed using the RNeasy Mini Kit (Qiagen), according to the manufacturer's protocol. Briefly, after 5 min incubation with the RNAprotect reagent, the sample was centrifuged for 10 min at 5000g, and the supernatant carefully discarded. Cell pellets were stored at À 80 1C until all replicates and conditions for that particular experiment were completed, allowing simultaneous purification of all samples. To account for variations in RNA loss among samples during the RNA purification process, 250 ng of an external mRNA standard (preparation described below) was spiked into each of the thawed pellets immediately prior to purification, as described previously (Amato and Brynildsen, 2014) . To eliminate potential DNA contamination, an on-column DNase digestion was performed using RNase-free DNase I (Qiagen). Sample purity and concentration were analyzed with a NanoDrop 1000 (Thermo Scientific), and stored at À 80 1C.
External mRNA standard synthesis
The mRNA standard was a synthetically transcribed gene (phzM) from P. aeruginosa, selected based on its absence from the E. coli chromosome. The phzM gene was cloned from purified P. aeruginosa PAO1 genomic DNA, and inserted into the pET-11a plasmid, such that its expression was under the control of the T7 phage promoter (Amato and Brynildsen, 2014) . The pET-11a-phzM plasmid was linearized by a 1 h restriction enzyme (RE) digest with EcoRI-HF s (New England Biolabs; NEB), and PCR-purified (Qiagen). The phzM mRNA was synthesized in vitro with the T7 High Yield RNA Synthesis Kit (NEB), using the linearized pET-11a-phzM plasmid as template, and the product mRNA was purified with the RNeasy Mini Kit (Qiagen), including an on-column DNase I digestion. Sample purity and concentration were measured on a NanoDrop 1000, and were stored at À 80 1C.
4.11.3. cDNA synthesis Purified mRNA ( $100 ng per sample) was converted to cDNA using TaqMan s Reverse Transcription Reagents (Life Technologies) according to the manufacturer's protocol, with a 10 mL reaction volume, using random hexamers. As a control, a second set of reverse transcription (RT) reactions were run, excluding the reverse transcriptase enzyme, to check for DNA contamination of the sample.
Real-time PCR
Real-time PCR was performed using the SYBR s Green PCR Master Mix (Applied Biosystems) in an optical 96-well PCR plate, with 20 ml reaction volumes consisting of 1 ml cDNA from RT reaction, 250 nM forward and reverse primers (Table S4) , and 10 ml of SYBR s Green PCR Master Mix. The PCR was run for 40 cycles using an ABI 7900 HT real-time thermocycler, and the C t (threshold cycle) values were obtained from the amplification curves. Each sample was run in separate reactions for phzM primers and target gene primers (and in biological triplicate or more), to allow quantification of phzM and target mRNA in each sample. To allow for absolute quantification of mRNA transcripts in each sample, standards were included on the PCR plate for each primer set, consisting of serial dilutions of the purified pET-11a-phzM plasmid and the plasmid carrying the target gene, allowing generation of concentration vs. C t calibration curves. Target gene concentrations were normalized by phzM concentrations in each sample to allow comparison among the different samples.
4.12. RNA sequencing (RNA-Seq)
WT or ΔclpP E. coli were grown and treated (or left untreated) with 250 μM DPTA NONOate identically as described for the NO • consumption assay (Section 4.6). After 10 min of treatment, 3 ml of culture was removed and immediately mixed with 6 ml of RNAprotect Bacteria Reagent (Qiagen). Total RNA was purified using the same procedure as described above for the qPCR analysis, except no phzM mRNA was delivered to the pellet prior to RNA purification. Each of the four conditions (WT and ΔclpP, untreated and treated) was performed in biological triplicate, yielding a total of 12 samples. Library preparation, sequencing, and data analysis are described in Text S1. The raw and processed RNA-Seq data from this publication have been submitted to the GEO database (http://www.ncbi.nlm.nih.gov/geo/) with accession number GSE60522.
Computational methods
Kinetic model description
All model simulations, calculations, and parametric analyses were performed using MATLAB (R2012a, The MathWorks Inc.). The kinetic model of the E. coli NO
• biochemical network used here was developed and described in previous studies (Robinson and Brynildsen, 2013; Robinson et al., 2014a) . Briefly, the model is comprised of a system of differential mass balances describing the change in species concentrations (X) subject to a network of chemical reactions (organized into a stoichiometry matrix, S), whose rates (r) are a function of kinetic parameters (p) and concentrations (x) of individual species dX dt ¼ S U rðx; pÞ
The model was partitioned into a media and cellular compartment, to facilitate comparisons and parameterization with experimental measurements. The system of differential equations was integrated numerically using the MATLAB ode15s function, yielding species concentrations over the specified time interval.
To allow a more mechanistic interrogation of the ΔclpP phenotype, protein synthesis, which was originally described by a single generation reaction, was partitioned into separate transcription and translation components. Production of mRNA transcripts was assumed to follow Hill-type kinetics, accounting for transcriptional regulation by fractional occupation of the relevant species (Sauro, 2012) , and degradation was assumed to follow first order decay kinetics (Laalami et al., 2014; Selinger et al., 2003) . The rates of protein translation were expressed as function of [mRNA] assuming elementary first-order kinetics, consistent with previous deterministic modeling studies (Usuda et al., 2010; Lee et al., 2011; Peercy et al., 2006; Belle et al., 2006; Nishio et al., 2008) . The reaction equations, rate expressions, and parameter values for transcription and translation of Hmp, NorV, and NrfA are presented in Table S5 , and the optimization of the new model components is described in Text S1 and Table S6 .
Model discrimination
The ensemble of models was used to identify experimental conditions in silico that resulted in a large variation in predictions among the different clpP À models. We note that error associated with parameters can introduce uncertainty into model simulations, and could therefore quantitatively change simulations where a difference between clpP þ and clpP À has been observed (enhance or reduce differences). Such uncertainty would need to be accounted for if elimination of models was performed based on absolute quantitative values. However, in recognition of this uncertainty and its potential effects, the model discrimination process was confined to qualitative binary decisions based on statistical analysis of the experimental data (e.g., difference/no difference). In this manner, conclusions drawn regarding the validity of a specific mechanism were independent of variation that would propagate from uncertainty in parameter values.
